CDC advisory panel recommends Pfizer and Modern vaccines over Johnson & Johnson
An advisory panel to the CDC unanimously voted to give a preferential recommendation to mRNA vaccines, like those made by Pfizer and Moderna, over the one-shot Johnson & Johnson vaccine due to rare but serious blood clots.
The CDC temporarily halted Johnson & Johnson’s vaccine in April while scientists investigated the blood clots, which are known as "thrombosis with thrombocytopenia syndrome."
An advisory panel to the CDC unanimously voted to give a preferential recommendation to mRNA vaccines, like those made by Pfizer and Moderna, over the one-shot Johnson & Johnson vaccine due to rare but serious blood clots.
The CDC temporarily halted Johnson & Johnson’s vaccine in April while scientists investigated the blood clots, which are known as "thrombosis with thrombocytopenia syndrome."